Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 5
2004 4
2005 7
2006 1
2007 5
2008 2
2009 5
2010 3
2011 2
2012 2
2013 1
2015 3
2017 2
2018 1
2019 4
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

48 results
Results by year
Filters applied: . Clear all
Page 1
Lymphangitic spread of invasive lobular carcinoma to the contralateral breast.
Burns Z, Omar L, Compton L, Hayes J, Sahoo S, Merchant K. Burns Z, et al. Among authors: sahoo s. Clin Imaging. 2019 Nov-Dec;58:187-190. doi: 10.1016/j.clinimag.2019.08.002. Epub 2019 Aug 13. Clin Imaging. 2019. PMID: 31450057
Isolated Contralateral Axillary Lymph Node Involvement in Breast Cancer Represents a Locally Advanced Disease Not Distant Metastases.
Chkheidze R, Sanders MAG, Haley B, Leitch AM, Sahoo S. Chkheidze R, et al. Among authors: sahoo s. Clin Breast Cancer. 2018 Aug;18(4):298-304. doi: 10.1016/j.clbc.2017.10.019. Epub 2017 Nov 10. Clin Breast Cancer. 2018. PMID: 29233470
Combined Targeting of Estrogen Receptor Alpha and XPO1 Prevent Akt Activation, Remodel Metabolic Pathways and Induce Autophagy to Overcome Tamoxifen Resistance.
Kulkoyluoglu-Cotul E, Smith BP, Wrobel K, Zhao YC, Chen KLA, Hieronymi K, Imir OB, Duong K, O'Callaghan C, Mehta A, Sahoo S, Haley B, Chang H, Landesman Y, Madak-Erdogan Z. Kulkoyluoglu-Cotul E, et al. Among authors: sahoo s. Cancers (Basel). 2019 Apr 4;11(4):479. doi: 10.3390/cancers11040479. Cancers (Basel). 2019. PMID: 30987380 Free PMC article.
Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial.
I-SPY2 Trial Consortium, Yee D, DeMichele AM, Yau C, Isaacs C, Symmans WF, Albain KS, Chen YY, Krings G, Wei S, Harada S, Datnow B, Fadare O, Klein M, Pambuccian S, Chen B, Adamson K, Sams S, Mhawech-Fauceglia P, Magliocco A, Feldman M, Rendi M, Sattar H, Zeck J, Ocal IT, Tawfik O, LeBeau LG, Sahoo S, Vinh T, Chien AJ, Forero-Torres A, Stringer-Reasor E, Wallace AM, Pusztai L, Boughey JC, Ellis ED, Elias AD, Lu J, Lang JE, Han HS, Clark AS, Nanda R, Northfelt DW, Khan QJ, Viscusi RK, Euhus DM, Edmiston KK, Chui SY, Kemmer K, Park JW, Liu MC, Olopade O, Leyland-Jones B, Tripathy D, Moulder SL, Rugo HS, Schwab R, Lo S, Helsten T, Beckwith H, Haugen P, Hylton NM, Van't Veer LJ, Perlmutter J, Melisko ME, Wilson A, Peterson G, Asare AL, Buxton MB, Paoloni M, Clennell JL, Hirst GL, Singhrao R, Steeg K, Matthews JB, Asare SM, Sanil A, Berry SM, Esserman LJ, Berry DA. I-SPY2 Trial Consortium, et al. Among authors: sahoo s. JAMA Oncol. 2020 Jul 23;6(9):1-9. doi: 10.1001/jamaoncol.2020.2535. Online ahead of print. JAMA Oncol. 2020. PMID: 32701140
Dystrophic epidermolysis bullosa.
Das BB, Sahoo S. Das BB, et al. Among authors: sahoo s. J Perinatol. 2004 Jan;24(1):41-7. doi: 10.1038/sj.jp.7211019. J Perinatol. 2004. PMID: 14726937 Review. No abstract available.
Malignant phylloides tumor in pregnancy.
Blaker KM, Sahoo S, Schweichler MR, Chagpar AB. Blaker KM, et al. Among authors: sahoo s. Am Surg. 2010 Mar;76(3):302-5. Am Surg. 2010. PMID: 20349661 Review.
Pathologic Findings of Breast Lesions Detected on Magnetic Resonance Imaging.
Jabbar SB, Lynch B, Seiler S, Hwang H, Sahoo S. Jabbar SB, et al. Among authors: sahoo s. Arch Pathol Lab Med. 2017 Nov;141(11):1513-1522. doi: 10.5858/arpa.2016-0552-OA. Epub 2017 Aug 7. Arch Pathol Lab Med. 2017. PMID: 28782985 Free article.
Comparison of Dako HercepTest and Ventana PATHWAY Anti-HER2 (4B5) Tests and Their Correlation With Fluorescent In Situ Hybridization in Breast Carcinoma.
Lucas E, Jabbar SB, Molberg K, Fang Y, Xie XJ, Blacketer S, Sahoo S. Lucas E, et al. Among authors: sahoo s. Appl Immunohistochem Mol Morphol. 2019 Jul;27(6):403-409. doi: 10.1097/PAI.0000000000000646. Appl Immunohistochem Mol Morphol. 2019. PMID: 31233398
48 results
Jump to page
Feedback